Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00515_DB01248_nanopub.RA2CZ7vTQ8pUTc79w7NaG--hwzVJ1LjRCgYoT1Uapinpo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00515_DB01248 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00515_DB01248 label "DDI between Cisplatin and Docetaxel - Platinum derivatives such as cisplatin may enhance the myelosuppressive effect of taxane derivatives such as docetaxel. Administer taxane derivative before platinum derivative when given as sequential infusions to limit toxicity. Administer paclitaxel before cisplatin, when given as sequential infusions, to limit toxicity. Problems associated with other taxane/platinum combinations are possible, although unsubstantiated. Administering the taxane derivative before the platinum derivative seems prudent. [drugbank_resource:DB00515_DB01248]" assertion.
- drugbank_resource:DB00515_DB01248 identifier "drugbank_resource:DB00515_DB01248" assertion.
- drugbank_resource:DB00515_DB01248 title "DDI between Cisplatin and Docetaxel - Platinum derivatives such as cisplatin may enhance the myelosuppressive effect of taxane derivatives such as docetaxel. Administer taxane derivative before platinum derivative when given as sequential infusions to limit toxicity. Administer paclitaxel before cisplatin, when given as sequential infusions, to limit toxicity. Problems associated with other taxane/platinum combinations are possible, although unsubstantiated. Administering the taxane derivative before the platinum derivative seems prudent." assertion.
- drugbank:DB00515 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00515_DB01248 assertion.
- drugbank:DB01248 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00515_DB01248 assertion.